RBA Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

RBA Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,799	Closed	-$243K	–	88
2023 Q2	$243K	Sell	3,799 -1,327	-26%	-$89K	0.11%	82
2023 Q1	$355K	Sell	5,126 -431	-8%	-$30.4K	0.18%	70
2022 Q4	$400K	Sell	5,557 -54,015	-91%	-$4.07M	0.21%	66
2022 Q3	$4.24M	Buy	59,572 +628	+1%	+$45.6K	2.44%	11
2022 Q2	$4.54M	Buy	58,944 +540	+0.9%	+$41.1K	2.52%	7
2022 Q1	$4.26M	Buy	58,404 +3,038	+5%	+$204K	2.05%	14
2021 Q4	$3.45M	Buy	55,366 +3,612	+7%	+$212K	1.63%	29
2021 Q3	$3.06M	Buy	51,754 +27,747	+116%	+$1.83M	7.38%	6
2021 Q2	$1.6M	Sell	24,007 -1,671	-7%	-$109K	3.41%	13
2021 Q1	$1.62M	Sell	25,678 -459	-2%	-$28.6K	1.38%	31
2020 Q4	$1.62M	Sell	26,137 -2,595	-9%	-$160K	0.98%	45
2020 Q3	$1.73M	Sell	28,732 -4,185	-13%	-$252K	1.17%	34
2020 Q2	$1.94M	Sell	32,917 -1,638	-5%	-$98K	1.41%	26
2020 Q1	$1.93M	Sell	34,555 -3,414	-9%	-$209K	1.67%	25
2019 Q4	$2.44M	Sell	37,969 -254	-0.7%	-$14.5K	1.66%	29
2019 Q3	$1.94M	Sell	38,223 -5,971	-14%	-$281K	1.48%	37
2019 Q2	$2M	Sell	44,194 -729	-2%	-$34K	1.55%	35
2019 Q1	$2.06M	Buy	+44,923	New	+$2.24M	1.61%	36

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

RBA Wealth Management's BMY Position: Q3 2023 in Review

RBA Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,799 shares — an estimated $243K sold.

RBA Wealth Management first reported a position in BMY in Q1 2019 and held it in 18 quarters. The position peaked at $4.54M in Q2 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

RBA Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
RBA Wealth Management sold 3,799 Bristol-Myers Squibb shares in Q3 2023, an estimated $243K.
RBA Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 18 quarters.
RBA Wealth Management's Bristol-Myers Squibb position peaked at $4.54M in Q2 2022.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on RBA Wealth Management's 13F filing for Q3 2023, filed 19 Oct 2023.